LBT INNOVATIONS LIMITED - Announcements

Market Cap $26.79M Add to my watchlist

Healthcare Medical Devices

LBT Innovations is a ground-breaking designer of advanced technology solutions for the... LBT Innovations is a ground-breaking designer of advanced technology solutions for the medical industry. We specialise in combining artificial intelligence, image analysis and software engineering to improve healthcare delivery. Our product, APAS® Independence, is a global first solution for automated reading of microbiology culture plates.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile

See benefits

Announcements

Filter Results

All Price Sensitive Only

LBT	Investor Webinar Presentation		09/09/21	160.7KB	Share
LBT	Appendix 4E and Annual Financial Statements	PRICE SENSITIVE	26/08/21	1.49MB	Share
LBT	Leading Microbiology Journal Publishes APAS Clinical Data		18/08/21	124.73KB	Share
LBT	Notification of cessation of securities - LBT		03/08/21	22.15KB	Share
LBT	Quarterly Activities/Appendix 4C Cash Flow Report	PRICE SENSITIVE	28/07/21	335.85KB	Share
LBT	APAS Independence Scientific Data Presented at ECCMID		09/07/21	133.67KB	Share
LBT	Proposed issue of securities - LBT		01/07/21	26.8KB	Share
LBT	Director Appointment/Resignation		01/07/21	238.89KB	Share
LBT	Market Update - US Commercial Progress		07/06/21	130.4KB	Share
LBT	Final Director's Interest Notice		31/05/21	131.11KB	Share
LBT	Non-Executive Director Retirement		31/05/21	109.48KB	Share
LBT	APAS Independence Sales to Health Services Laboratory, UK	PRICE SENSITIVE	18/05/21	128.66KB	Share
LBT	Change of Registered Office and Principal Place of Business		14/05/21	80.54KB	Share
LBT	Appendix 4C - quarterly	PRICE SENSITIVE	29/04/21	368.76KB	Share
LBT	Lapse of Unlisted Options		15/04/21	105.2KB	Share
LBT	Market Update - Distributors & Sales Activities		12/04/21	131.69KB	Share
LBT	Proposed issue of Securities - LBT		26/03/21	25.72KB	Share
LBT	Directors Purchase of Shares		26/03/21	114.27KB	Share
LBT	CEO Presentation - ShareCafe Webinar		25/03/21	1021.46KB	Share
LBT	LBT Receives $0.83 Million R&D Tax Incentive		26/02/21	102.91KB	Share
LBT	Half Yearly Report and Accounts	PRICE SENSITIVE	19/02/21	822.04KB	Share
LBT	Market Update - Board Renewal Process	PRICE SENSITIVE	01/02/21	123.51KB	Share
LBT	Appendix 4C - quarterly	PRICE SENSITIVE	29/01/21	348.28KB	Share
LBT	Change of Director's Interest Notice		24/12/20	176.39KB	Share
LBT	Appendix 3G		24/12/20	273.78KB	Share
LBT	Cleansing Notice - Notice Under Section 708A		18/12/20	101.88KB	Share
LBT	Appendix 3G		18/12/20	272.13KB	Share
LBT	Appendix 2A		18/12/20	275.14KB	Share
LBT	Proposed issue of Securities - LBT		17/12/20	29.56KB	Share
LBT	Market Update - EU Commercial Activities		15/12/20	150.3KB	Share
LBT	Results of Meeting		25/11/20	122.4KB	Share
LBT	CEO Presentation - AGM 2020		25/11/20	771.58KB	Share
LBT	Chairman's Address to Shareholders		25/11/20	133.4KB	Share
LBT	Updated Requirements for Annual General Meeting		18/11/20	158.69KB	Share
LBT	Presentation at Australia Biotech Invest & Partnering 2020		27/10/20	1.26MB	Share
LBT	Appendix 4C - quarterly	PRICE SENSITIVE	27/10/20	352.13KB	Share
LBT	Timing of Quarterly Results & Investor Call		22/10/20	109.68KB	Share
LBT	Notice of Annual General Meeting/Proxy Form		22/10/20	591.8KB	Share
LBT	Sale of APAS Independence to Germany's Limbach Group of Labs		12/10/20	144.79KB	Share
LBT	Appendix 2A		09/10/20	532.66KB	Share
LBT	Lapse of Unlisted Options		09/10/20	100.04KB	Share
LBT	Appendix 4G		02/10/20	264.54KB	Share
LBT	Corporate Governance Statement		02/10/20	268.43KB	Share
LBT	Annual Report to shareholders		02/10/20	4.15MB	Share
LBT	Investor Webinar Presentation		09/09/20	127.96KB	Share
LBT	$0.75m Funding Awarded for APAS-AMR Analysis Module	PRICE SENSITIVE	03/09/20	584.65KB	Share
LBT	Appendix 3G		01/09/20	467.5KB	Share
LBT	Annual Financial Report		27/08/20	1.22MB	Share
LBT	Appendix 4E	PRICE SENSITIVE	27/08/20	122.55KB	Share
LBT	Appendix 2A		17/08/20	274.86KB	Share
LBT	Share Purchase Plan Results		12/08/20	104.88KB	Share
LBT	Cleansing Notice - Notice Under Section 708A		07/08/20	101.46KB	Share
LBT	Details of Quarterly Investor Call		04/08/20	109.32KB	Share
LBT	Appendix 2A		04/08/20	523.84KB	Share
LBT	Appendix 4C - quarterly	PRICE SENSITIVE	29/07/20	378.29KB	Share
LBT	Share Purchase Plan		17/07/20	581.81KB	Share
LBT	Cleansing Notice - Notice Under Section 708A		16/07/20	102.87KB	Share
LBT	First Placement of APAS Independence in UK Lab		16/07/20	223.3KB	Share
LBT	Appendix 2A		15/07/20	275.12KB	Share
LBT	Oneservice Appointed Managed Service Provider for APAS	PRICE SENSITIVE	13/07/20	145.38KB	Share
LBT	Proposed issue of Securities - LBT	PRICE SENSITIVE	09/07/20	34.63KB	Share
LBT	$8M PRIVATE PLACEMENT & LAUNCH OF SPP	PRICE SENSITIVE	09/07/20	1.56MB	Share
LBT	Trading Halt	PRICE SENSITIVE	07/07/20	338.52KB	Share
LBT	Pause in Trading	PRICE SENSITIVE	07/07/20	115.04KB	Share
LBT	LBT TEAMS WITH GLOBAL CLINICAL DIAGNOSTICS COMPANY	PRICE SENSITIVE	07/07/20	316KB	Share
LBT	Results of Evaluation of APAS Independence by Johns Hopkins	PRICE SENSITIVE	30/06/20	451.88KB	Share
LBT	First Sale of APAS Independence in United States	PRICE SENSITIVE	09/06/20	135.7KB	Share
LBT	Employee Incentive Plan		05/06/20	143.35KB	Share
LBT	Update on MRSA Analysis Module US FDA Submission	PRICE SENSITIVE	04/06/20	164.71KB	Share
LBT	$1.5M Draw Down on South Australian Government Loan	PRICE SENSITIVE	26/05/20	145.68KB	Share
LBT	Presentation at Finance News Network Online Event		19/05/20	126.15KB	Share
LBT	South Australian Government Agree to Extend Loan Facility	PRICE SENSITIVE	08/05/20	131.29KB	Share
LBT	Presentation at NWR Virtual Small Cap Conference	PRICE SENSITIVE	30/04/20	1.42MB	Share
LBT	Appendix 4C - quarterly	PRICE SENSITIVE	28/04/20	343.93KB	Share
LBT	US FDA 510(k) Submission for MRSA Analysis Module	PRICE SENSITIVE	30/03/20	136.56KB	Share
LBT	VRE Analysis Module - Clinical Study Commenced	PRICE SENSITIVE	19/03/20	135.38KB	Share
LBT	Johns Hopkins Hosp to Present Study Data APAS Independence	PRICE SENSITIVE	12/03/20	155.67KB	Share
LBT	Half Yearly Report and Accounts	PRICE SENSITIVE	27/02/20	755.69KB	Share
LBT	Company Secretary Appointment/Resignation		10/02/20	126.66KB	Share
LBT	Appendix 4C - quarterly	PRICE SENSITIVE	30/01/20	323.01KB	Share
LBT	LBT Receives $1.1 Million R&D Tax Incentive	PRICE SENSITIVE	22/01/20	101.73KB	Share
LBT	Presentation at Biotech Showcase Investor Conference	PRICE SENSITIVE	14/01/20	1.52MB	Share
LBT	Change of Director's Interest Notice		12/12/19	162.64KB	Share
LBT	Change of Director's Interest Notice		11/12/19	162.54KB	Share
LBT	Appendix 3B		10/12/19	400.03KB	Share
LBT	Appendix 3B		28/11/19	397.07KB	Share
LBT	Results of Meeting		27/11/19	108.11KB	Share
LBT	CEO Presentation - AGM 2019	PRICE SENSITIVE	27/11/19	1.42MB	Share
LBT	Chairman's Address to Shareholders	PRICE SENSITIVE	27/11/19	109.92KB	Share
LBT	Appendix 3B		14/11/19	361.84KB	Share
LBT	Presentation at Australia Biotech Invest & Partnering 2019		31/10/19	125.7KB	Share
LBT	Final Director's Interest Notice		30/10/19	131.77KB	Share
LBT	Non-Executive Director Retirement	PRICE SENSITIVE	30/10/19	128.69KB	Share
LBT	Appendix 4C - quarterly	PRICE SENSITIVE	25/10/19	298.57KB	Share
LBT	Notice of Annual General Meeting/Proxy Form		22/10/19	360.39KB	Share
LBT	First European Sale of APAS Independence	PRICE SENSITIVE	21/10/19	145.61KB	Share
LBT	LBT Presents at Australian Microcap Investment Conference		21/10/19	102.5KB	Share
LBT	Appendix 4G		30/09/19	271.86KB	Share
LBT	Corporate Governance Statement		30/09/19	252.44KB	Share
LBT	Annual Report to shareholders		30/09/19	3.38MB	Share

LBT Investor Webinar Presentation
09/09/21		160.7KB	Share
LBT Appendix 4E and Annual Financial Statements
26/08/21	PRICE SENSITIVE	1.49MB	Share
LBT Leading Microbiology Journal Publishes APAS Clinical Data
18/08/21		124.73KB	Share
LBT Notification of cessation of securities - LBT
03/08/21		22.15KB	Share
LBT Quarterly Activities/Appendix 4C Cash Flow Report
28/07/21	PRICE SENSITIVE	335.85KB	Share
LBT APAS Independence Scientific Data Presented at ECCMID
09/07/21		133.67KB	Share
LBT Proposed issue of securities - LBT
01/07/21		26.8KB	Share
LBT Director Appointment/Resignation
01/07/21		238.89KB	Share
LBT Market Update - US Commercial Progress
07/06/21		130.4KB	Share
LBT Final Director's Interest Notice
31/05/21		131.11KB	Share
LBT Non-Executive Director Retirement
31/05/21		109.48KB	Share
LBT APAS Independence Sales to Health Services Laboratory, UK
18/05/21	PRICE SENSITIVE	128.66KB	Share
LBT Change of Registered Office and Principal Place of Business
14/05/21		80.54KB	Share
LBT Appendix 4C - quarterly
29/04/21	PRICE SENSITIVE	368.76KB	Share
LBT Lapse of Unlisted Options
15/04/21		105.2KB	Share
LBT Market Update - Distributors & Sales Activities
12/04/21		131.69KB	Share
LBT Proposed issue of Securities - LBT
26/03/21		25.72KB	Share
LBT Directors Purchase of Shares
26/03/21		114.27KB	Share
LBT CEO Presentation - ShareCafe Webinar
25/03/21		1021.46KB	Share
LBT LBT Receives $0.83 Million R&D Tax Incentive
26/02/21		102.91KB	Share
LBT Half Yearly Report and Accounts
19/02/21	PRICE SENSITIVE	822.04KB	Share
LBT Market Update - Board Renewal Process
01/02/21	PRICE SENSITIVE	123.51KB	Share
LBT Appendix 4C - quarterly
29/01/21	PRICE SENSITIVE	348.28KB	Share
LBT Change of Director's Interest Notice
24/12/20		176.39KB	Share
LBT Appendix 3G
24/12/20		273.78KB	Share
LBT Cleansing Notice - Notice Under Section 708A
18/12/20		101.88KB	Share
LBT Appendix 3G
18/12/20		272.13KB	Share
LBT Appendix 2A
18/12/20		275.14KB	Share
LBT Proposed issue of Securities - LBT
17/12/20		29.56KB	Share
LBT Market Update - EU Commercial Activities
15/12/20		150.3KB	Share
LBT Results of Meeting
25/11/20		122.4KB	Share
LBT CEO Presentation - AGM 2020
25/11/20		771.58KB	Share
LBT Chairman's Address to Shareholders
25/11/20		133.4KB	Share
LBT Updated Requirements for Annual General Meeting
18/11/20		158.69KB	Share
LBT Presentation at Australia Biotech Invest & Partnering 2020
27/10/20		1.26MB	Share
LBT Appendix 4C - quarterly
27/10/20	PRICE SENSITIVE	352.13KB	Share
LBT Timing of Quarterly Results & Investor Call
22/10/20		109.68KB	Share
LBT Notice of Annual General Meeting/Proxy Form
22/10/20		591.8KB	Share
LBT Sale of APAS Independence to Germany's Limbach Group of Labs
12/10/20		144.79KB	Share
LBT Appendix 2A
09/10/20		532.66KB	Share
LBT Lapse of Unlisted Options
09/10/20		100.04KB	Share
LBT Appendix 4G
02/10/20		264.54KB	Share
LBT Corporate Governance Statement
02/10/20		268.43KB	Share
LBT Annual Report to shareholders
02/10/20		4.15MB	Share
LBT Investor Webinar Presentation
09/09/20		127.96KB	Share
LBT $0.75m Funding Awarded for APAS-AMR Analysis Module
03/09/20	PRICE SENSITIVE	584.65KB	Share
LBT Appendix 3G
01/09/20		467.5KB	Share
LBT Annual Financial Report
27/08/20		1.22MB	Share
LBT Appendix 4E
27/08/20	PRICE SENSITIVE	122.55KB	Share
LBT Appendix 2A
17/08/20		274.86KB	Share
LBT Share Purchase Plan Results
12/08/20		104.88KB	Share
LBT Cleansing Notice - Notice Under Section 708A
07/08/20		101.46KB	Share
LBT Details of Quarterly Investor Call
04/08/20		109.32KB	Share
LBT Appendix 2A
04/08/20		523.84KB	Share
LBT Appendix 4C - quarterly
29/07/20	PRICE SENSITIVE	378.29KB	Share
LBT Share Purchase Plan
17/07/20		581.81KB	Share
LBT Cleansing Notice - Notice Under Section 708A
16/07/20		102.87KB	Share
LBT First Placement of APAS Independence in UK Lab
16/07/20		223.3KB	Share
LBT Appendix 2A
15/07/20		275.12KB	Share
LBT Oneservice Appointed Managed Service Provider for APAS
13/07/20	PRICE SENSITIVE	145.38KB	Share
LBT Proposed issue of Securities - LBT
09/07/20	PRICE SENSITIVE	34.63KB	Share
LBT $8M PRIVATE PLACEMENT & LAUNCH OF SPP
09/07/20	PRICE SENSITIVE	1.56MB	Share
LBT Trading Halt
07/07/20	PRICE SENSITIVE	338.52KB	Share
LBT Pause in Trading
07/07/20	PRICE SENSITIVE	115.04KB	Share
LBT LBT TEAMS WITH GLOBAL CLINICAL DIAGNOSTICS COMPANY
07/07/20	PRICE SENSITIVE	316KB	Share
LBT Results of Evaluation of APAS Independence by Johns Hopkins
30/06/20	PRICE SENSITIVE	451.88KB	Share
LBT First Sale of APAS Independence in United States
09/06/20	PRICE SENSITIVE	135.7KB	Share
LBT Employee Incentive Plan
05/06/20		143.35KB	Share
LBT Update on MRSA Analysis Module US FDA Submission
04/06/20	PRICE SENSITIVE	164.71KB	Share
LBT $1.5M Draw Down on South Australian Government Loan
26/05/20	PRICE SENSITIVE	145.68KB	Share
LBT Presentation at Finance News Network Online Event
19/05/20		126.15KB	Share
LBT South Australian Government Agree to Extend Loan Facility
08/05/20	PRICE SENSITIVE	131.29KB	Share
LBT Presentation at NWR Virtual Small Cap Conference
30/04/20	PRICE SENSITIVE	1.42MB	Share
LBT Appendix 4C - quarterly
28/04/20	PRICE SENSITIVE	343.93KB	Share
LBT US FDA 510(k) Submission for MRSA Analysis Module
30/03/20	PRICE SENSITIVE	136.56KB	Share
LBT VRE Analysis Module - Clinical Study Commenced
19/03/20	PRICE SENSITIVE	135.38KB	Share
LBT Johns Hopkins Hosp to Present Study Data APAS Independence
12/03/20	PRICE SENSITIVE	155.67KB	Share
LBT Half Yearly Report and Accounts
27/02/20	PRICE SENSITIVE	755.69KB	Share
LBT Company Secretary Appointment/Resignation
10/02/20		126.66KB	Share
LBT Appendix 4C - quarterly
30/01/20	PRICE SENSITIVE	323.01KB	Share
LBT LBT Receives $1.1 Million R&D Tax Incentive
22/01/20	PRICE SENSITIVE	101.73KB	Share
LBT Presentation at Biotech Showcase Investor Conference
14/01/20	PRICE SENSITIVE	1.52MB	Share
LBT Change of Director's Interest Notice
12/12/19		162.64KB	Share
LBT Change of Director's Interest Notice
11/12/19		162.54KB	Share
LBT Appendix 3B
10/12/19		400.03KB	Share
LBT Appendix 3B
28/11/19		397.07KB	Share
LBT Results of Meeting
27/11/19		108.11KB	Share
LBT CEO Presentation - AGM 2019
27/11/19	PRICE SENSITIVE	1.42MB	Share
LBT Chairman's Address to Shareholders
27/11/19	PRICE SENSITIVE	109.92KB	Share
LBT Appendix 3B
14/11/19		361.84KB	Share
LBT Presentation at Australia Biotech Invest & Partnering 2019
31/10/19		125.7KB	Share
LBT Final Director's Interest Notice
30/10/19		131.77KB	Share
LBT Non-Executive Director Retirement
30/10/19	PRICE SENSITIVE	128.69KB	Share
LBT Appendix 4C - quarterly
25/10/19	PRICE SENSITIVE	298.57KB	Share
LBT Notice of Annual General Meeting/Proxy Form
22/10/19		360.39KB	Share
LBT First European Sale of APAS Independence
21/10/19	PRICE SENSITIVE	145.61KB	Share
LBT LBT Presents at Australian Microcap Investment Conference
21/10/19		102.5KB	Share
LBT Appendix 4G
30/09/19		271.86KB	Share
LBT Corporate Governance Statement
30/09/19		252.44KB	Share
LBT Annual Report to shareholders
30/09/19		3.38MB	Share

REFRESH

First 2 3 4 5 6

(20min delay)
Last 2.0¢		Change 0.001(5.26%)		Mkt cap ! $26.79M

Open	High	Low	Value	Volume
1.9¢	2.0¢	1.9¢	$1.342K	68K

Buyers (Bids)

No.	Vol.	Price($)
6	2127628	1.9¢

Sellers (Offers)

Price($)	Vol.	No.
2.0¢	200000	1

View Market Depth

No.	Vol.	Price($)
6	2127628	0.019
2	250000	0.018
1	100000	0.017
3	480000	0.016
3	731666	0.015

Price($)	Vol.	No.
0.020	200000	1
0.021	170000	2
0.022	683000	7
0.023	545922	2
0.024	650000	5

Last trade - 14.00pm 26/04/2024 (20 minute delay)


Last 1.9¢		Change 0.001 ( 0.00 %)
Open	High	Low	Volume
1.9¢	1.9¢	1.9¢	82000
Last updated 10.35am 26/04/2024 ?

LBT (ASX) Chart

LBT INNOVATIONS LIMITED - Announcements

Corporate SpotlightNot Yet Available

Announcements

Buyers (Bids)

Sellers (Offers)

Top Stories

Corporate Spotlight
Not Yet Available